The presence of TFF3 staining, beta-catenin expression and loss of MMR protein expression appears useful in diagnosing grade 3 endometrioid carcinoma and these markers may be included in extended panels. The gene discussed is TFF3; the disease is endometrioid adenocarcinoma.